Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bioqual's dividends per share for the
three
months ended in Nov. 2025 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Nov. 2025 was $0.00. Its Dividend Payout Ratio for the
three
months ended in Nov. 2025 was 0.00. As of today, Bioqual's Dividend Yield % is 0.00%.
During the past 3 years, the average Dividends Per Share Growth Rate was 55.40% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 45.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Bioqual was 59.90% per year. The lowest was 17.00% per year. And the median was 43.55% per year.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
During the past 13 years, the highest Dividend Payout Ratio of Bioqual was 0.36. The lowest was 0.08. And the median was 0.13.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
During the past 13 years, the highest Dividend Yield of Bioqual was 1.35%. The lowest was 0.00%. And the median was 1.12%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioqual Dividends per Share Related Terms
Bioqual Dividends per Share Historical Data
* Premium members only.
The historical data trend for Bioqual's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BIOQ vs ADVB, QUCY, MDXH: Dividends per Share Comparison
For the Diagnostics & Research subindustry, Bioqual's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioqual Dividend Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Bioqual's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Bioqual's Dividend Yield % falls into.
Bioqual (BIOQ) has a Dividends per Share of $0.00 as of Nov. 2025. Dividends per share represents the per-share amount paid as dividends. View historical data on Bioqual and its competitors.
Is Bioqual's Dividends per Share too high?
Bioqual's current Dividends per Share is $0.00. Overall, Bioqual has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Bioqual's Dividends per Share compare to ADVB and QUCY?
Bioqual's Dividends per Share of $0.00 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Medical Diagnostics & Research company?
A good Dividends per Share depends on the Medical Diagnostics & Research industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Bioqual and its competitors. Bioqual's current Dividends per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioqual stock overvalued right now?
Bioqual (BIOQ) has a current Dividends per Share of $0.00. The current Dividends per Share is $0.00. Bioqual's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Bioqual (BIOQ), the current Dividends per Share is $0.00 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
54GF Score
Get the complete analysis for BIOQ
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BIOQ has been successfully added to your 
